Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis

United European Gastroenterology Journal

Volumn 4, Issue 5, 2016, Pages 697-705

  Capurso, Gabriele ^a   Signoretti, Marianna ^a   Archibugi, Livia ^a   Stigliano, Serena ^a   Delle Fave, Gianfranco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic pancreatitis; nutrition; pancreatic exocrine insufficiency; small intestinal bacterial overgrowth; symptoms

Indexed keywords

DOXYCYCLINE; LACTULOSE; METRONIDAZOLE; RIFAXIMIN; VITAMIN D;

ARTICLE; BACTERIAL OVERGROWTH; CHRONIC PANCREATITIS; DIARRHEA; GASTROINTESTINAL SURGERY; GENETIC HETEROGENEITY; HUMAN; IMMUNE DEFICIENCY; INTESTINE FLORA; NEUROGENIC BOWEL; NUTRITIONAL STATUS; PRIORITY JOURNAL; SMALL INTESTINE; SYSTEMATIC REVIEW;

EID: 84988878407     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640616630117     Document Type: Article

References (34)

1. Lévy P, Domínguez-Muñoz E, Imrie C. Epidemiology of chronic pancreatitis: Burden of the disease and consequences. United European Gastroenterol J 2014; 2: 345–354.
2. Burton F, Alkaade S, Collins D. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States. Aliment Pharmacol Ther 2011; 33: 149–159.
3. Frulloni L, Falconi M, Gabbrielli A. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010; 42: S381–S406.
4. Gubergrits N, Malecka-Panas E, Lehman GA. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther 2011; 33: 1152–1161.
5. Martínez J, Abad-González A, Aparicio JR. The Spanish Pancreatic Club recommendations for the diagnosis and treatment of chronic pancreatitis: Part 1 (diagnosis). Pancreatology 2013; 13: 8–17.
6. Pezzilli R, Andriulli A, Bassi C, et al. Exocrine Pancreatic Insufficiency collaborative (EPIc) Group. Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol 2013 28; 19: 7930–7946
7. Grace E, Shaw C, Whelan K. Review article: Small intestinal bacterial overgrowth–prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 2013; 38: 674–688.
8. Gasbarrini A, Corazza GR, Gasbarrini G. 1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: The Rome Consensus Conference. Aliment Pharmacol Ther 2009; 29: 1–49.
9. Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: Maximizing test accuracy. Clin Gastroenterol Hepatol 2014; 12: 1964–1972.
10. Casellas F, Guarner L, Vaquero E. Hydrogen breath test with glucose in exocrine pancreatic insufficiency. Pancreas 1998; 16: 481–486.
11. Madsen JL, Graff J, Philipsen EK. Bile acid malabsorption or disturbed intestinal permeability in patients treated with enzyme substitution for exocrine pancreatic insufficiency is not caused by bacterial overgrowth. Pancreas 2003; 26: 130–133.
12. Signoretti M, Stigliano S, Valente R. Small intestinal bacterial overgrowth in patients with chronic pancreatitis. J Clin Gastroenterol 2014; 48: S52–S55.
13. Moher D, Liberati A, Tetzlaff J. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6: e1000097–e1000097.
14. Moga C, Guo B. Development of a quality appraisal tool for case series studies using a modified Delphi technique, Edmonton, AB: Institute of Health Economics, 2012.
15. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses, www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 18 April 2012)
16. Sutton AJ. Methods for meta-analysis in medical research, New York, NY: John Wiley, 2000.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
19. Mancilla AC, Madrid SAM, Hurtado HC. Small intestine bacterial overgrowth in patients with chronic pancreatitis. Rev Med Chil 2008; 136: 976–980.
20. Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin 1999; 15: 47–52.
21. Grigor'eva IuV, Iakovenko ÉP, Volosheˇnikova TV. The clinical manifestations and duodenal mucosa in the patients with chronic pancreatitis and bacterial overgrowth in the small intestine. Eksp Klin Gastroenterol 2010; 11: 29–34.
22. Kumar K, Ghoshal UC, Srivastava D. Small intestinal bacterial overgrowth is common both among patients with alcoholic and idiopathic chronic pancreatitis. Pancreatology 2014; 14: 280–283.
23. Lembcke B, Kraus B, Lankisch PG. Small intestinal function in chronic relapsing pancreatitis. Hepatogastroenterology 1985; 32: 149–151.
24. Kim DB, Paik CN, Sung HJ. Breath hydrogen and methane are associated with intestinal symptoms in patients with chronic pancreatitis. Pancreatology 2015; 15: 514–518.
25. Posserud I, Stotzer PO, Björnsson ES. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802–808.
26. Lin HC. Small intestinal bacterial overgrowth: A framework for understanding irritable bowel syndrome. JAMA 2004; 292: 852–858.
27. Rana SV, Sharma S, Kaur J. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth inpatients with irritable bowel syndrome. Digestion 2012; 85: 243–247.
28. Ghoshal UC, Srivastava D, Ghoshal U. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur J Gastroenterol Hepatol 2014; 26: 753–760.
29. Petrone P, Sarkisyan G, Fernández M. Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery. Arch Surg 2011; 146: 444–447.
30. Gabbard SL, Lacy BE, Levine GM. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci 2014; 59: 638–644.
31. Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: A meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 483–490.
32. Ojetti V, Pitocco D, Scarpellini E. Small bowel bacterial overgrowth and type 1 diabetes. Eur Rev Med Pharmacol Sci 2009; 13: 419–423.
33. Domínguez-Muñoz JE. Chronic pancreatitis and persistent steatorrhea: What is the correct dose of enzymes? Clin Gastroenterol Hepatol 2011; 9: 541–546.
34. Shah SC, Day LW, Somsouk M. Meta-analysis: Antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2013; 38: 925–934.